Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14875-14883
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14875
Figure 1
Figure 1 Degree of hepatic fibrosis among groups (Masson staining, × 200). A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.
Figure 2
Figure 2 Immunohistochemical analysis of Gremlin expression in rats of each group (× 400). A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.
Figure 3
Figure 3 Western blot analysis of Gremlin expression in rats of each group. A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.
Figure 4
Figure 4 Immunohistochemical analysis of bone morphogenetic protein-7 expression in rats of each group (× 400). A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.
Figure 5
Figure 5 Western blot analysis of bone morphogenetic protein-7 expression in rats of each group. A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group. BMP-7: Bone morphogenetic protein-7.